These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 21796525)

  • 1. Methods to study dynamic interaction of androgen receptor with chromatin in living cells.
    Kirli HZ; Saatcioglu F
    Methods Mol Biol; 2011; 776():131-45. PubMed ID: 21796525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell analysis of glucocorticoid receptor action reveals that stochastic post-chromatin association mechanisms regulate ligand-specific transcription.
    Voss TC; John S; Hager GL
    Mol Endocrinol; 2006 Nov; 20(11):2641-55. PubMed ID: 16873444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
    Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA
    J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of gene targeting and chromatin remodelling by nuclear receptors.
    Hager GL; Fletcher TM; Xiao N; Baumann CT; Müller WG; McNally JG
    Biochem Soc Trans; 2000; 28(4):405-10. PubMed ID: 10961929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter.
    List HJ; Smith CL; Rodriguez O; Danielsen M; Riegel AT
    Exp Cell Res; 1999 Nov; 252(2):471-8. PubMed ID: 10527637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiandrogens prevent stable DNA-binding of the androgen receptor.
    Farla P; Hersmus R; Trapman J; Houtsmuller AB
    J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.
    List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT
    Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The androgen receptor ligand-binding domain stabilizes DNA binding in living cells.
    Farla P; Hersmus R; Geverts B; Mari PO; Nigg AL; Dubbink HJ; Trapman J; Houtsmuller AB
    J Struct Biol; 2004 Jul; 147(1):50-61. PubMed ID: 15109605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FRAP and FRET methods to study nuclear receptors in living cells.
    van Royen ME; Dinant C; Farla P; Trapman J; Houtsmuller AB
    Methods Mol Biol; 2009; 505():69-96. PubMed ID: 19117140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
    Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
    Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmentalization of androgen receptor protein-protein interactions in living cells.
    van Royen ME; Cunha SM; Brink MC; Mattern KA; Nigg AL; Dubbink HJ; Verschure PJ; Trapman J; Houtsmuller AB
    J Cell Biol; 2007 Apr; 177(1):63-72. PubMed ID: 17420290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter.
    List HJ; Smith CL; Martinez E; Harris VK; Danielsen M; Riegel AT
    Exp Cell Res; 2000 Oct; 260(1):160-5. PubMed ID: 11010820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence recovery after photobleaching (FRAP) to study nuclear protein dynamics in living cells.
    van Royen ME; Farla P; Mattern KA; Geverts B; Trapman J; Houtsmuller AB
    Methods Mol Biol; 2009; 464():363-85. PubMed ID: 18951195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
    Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
    Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrogating androgen receptor function in recurrent prostate cancer.
    Zhang L; Johnson M; Le KH; Sato M; Ilagan R; Iyer M; Gambhir SS; Wu L; Carey M
    Cancer Res; 2003 Aug; 63(15):4552-60. PubMed ID: 12907631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
    Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
    Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of mammalian NER proteins.
    Vermeulen W
    DNA Repair (Amst); 2011 Jul; 10(7):760-71. PubMed ID: 21550320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.